Ibuprofen linked to sharply lower Alzheimer’s risk
Long-term use of ibuprofen and similar drugs commonly used to treat aches and pains was associated with a sharply lower risk of Alzheimer’s disease in a study of nearly a quarter million ageing veterans in the USA.
This longest study of its kind, published online in the journal Neurology follows previous research that produced conflicting results on whether ibuprofen lowered the risk of dementia.
The study found that people who specifically used ibuprofen for more than five years were more than 40% less likely to develop Alzheimer’s disease.
Results also showed that the longer ibuprofen was used, the lower the risk for dementia.
In addition, people who used other certain types of NSAIDs for more than five years were 25% less likely to develop Alzheimer’s disease than non-users.
